Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats
- 25 September 2000
- journal article
- Published by Elsevier BV in Journal of Reproductive Immunology
- Vol. 48 (2), 81-98
- https://doi.org/10.1016/s0165-0378(00)00073-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine productionFertility and Sterility, 1998
- Peritoneal Cellular Immunity and EndometriosisAmerican Journal of Reproductive Immunology, 1997
- Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endometriosisAmerican Journal of Obstetrics and Gynecology, 1996
- Endocrinology and paracrinologyMolecular Human Reproduction, 1996
- Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in cultureAmerican Journal of Obstetrics and Gynecology, 1995
- Spontaneous and steroid-induced recurrence of endometriosis after suppression by a gonadotropin-releasing hormone antagonist in the ratAmerican Journal of Obstetrics and Gynecology, 1991
- Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosisAmerican Journal of Obstetrics and Gynecology, 1990
- Comparison of the pharmacology of nafarelin and danazolAmerican Journal of Obstetrics and Gynecology, 1990
- Human monocyte chemoattractant protein-1 (MCP-1)Immunology Today, 1990
- New Therapy for EndometriosisNew England Journal of Medicine, 1988